Gastroenterology Research and Practice / 2009 / Article / Tab 4

Clinical Study

Short Bowel Patients Treated for Two Years with Glucagon-Like Peptide 2 (GLP-2): Compliance, Safety, and Effects on Quality of Life

Table 4

Inflammatory Bowel Disease Questionnaire, IBDQ (7 Best).

( )1st year2nd year

BaselineWeek 13Week 26Week 52WashoutWeek 13Week 26Week 52P-value

TreatmentNoneGLP-2GLP-2GLP-2NoneGLP-2GLP-2 + Cholyl-sarcosineGLP-2
Overall 0.007
Bowel Symptoms 0.61
Systemic Symptoms 0.03
Emotional Function 0.44
Social Function 0.03

* compared to baseline by Dunnett’s test.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.